Group II metabotropic glutamate receptor antagonism prevents the antiallodynic effects of R-isovaline
- PMID:25701709
- DOI: 10.1016/j.neuroscience.2015.02.022
Group II metabotropic glutamate receptor antagonism prevents the antiallodynic effects of R-isovaline
Abstract
We previously showed that isovaline is a peripheral analgesic which acts in vivo and in brain slices as an atypical metabotropic GABA(B) agonist. Peripheral inhibitory group II and III metabotropic glutamate receptors (mGluRs) belong to the same family C as GABA(B) receptors; therefore, we hypothesized that isovaline's analgesic effects could include their activation. We examined the effects of R-isovaline on mechanical allodynia produced by prostaglandin E2 in the mouse paw. Subcutaneous R-isovaline produced dose-dependent antiallodynia restricted to the injected hindlimb. This antiallodynia was blocked by co-injection with a selective group II mGluR antagonist, LY341495, but not a group III mGluR antagonist (MAP-4). The antiallodynic effect of R-isovaline was potentiated by co-administration of a group II mGluR-positive allosteric modulator, LY487379. Injection of a group II mGluR agonist (LY354740) produced an antiallodynic effect which was completely reversed by group II antagonism, but was not affected by group III or GABA(B) (CGP35348) antagonism. Similarly, group II mGluR antagonism did not alter the antiallodynia produced by the prototypical GABA(B) agonist, baclofen. Hence, there was no apparent crosstalk between group II mGluRs and GABA(B) receptors. Previous studies have demonstrated that peripheral GABA(B) receptor activation by isovaline produces antiallodynia. In addition, the present results indicate that activation of peripheral group II mGluRs by R-isovaline produces antiallodynia.
Keywords: GABA(B); analgesia; antiallodynia; isovaline; mGluR II; peripheral pain.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
Similar articles
- GABA(B) receptor-mediated selective peripheral analgesia by the non-proteinogenic amino acid, isovaline.Whitehead RA, Puil E, Ries CR, Schwarz SK, Wall RA, Cooke JE, Putrenko I, Sallam NA, MacLeod BA.Whitehead RA, et al.Neuroscience. 2012 Jun 28;213:154-60. doi: 10.1016/j.neuroscience.2012.04.026. Epub 2012 Apr 21.Neuroscience. 2012.PMID:22525135
- Central metabotropic glutamate receptors differentially participate in interleukin-1beta-induced mechanical allodynia in the orofacial area of conscious rats.Jung CY, Choi HS, Ju JS, Park HS, Kwon TG, Bae YC, Ahn DK.Jung CY, et al.J Pain. 2006 Oct;7(10):747-56. doi: 10.1016/j.jpain.2006.03.007.J Pain. 2006.PMID:17018335
- Differential effects of R-isovaline and the GABAB agonist, baclofen, in the guinea pig ileum.Fung T, Asseri KA, Asiri YI, Wall RA, Schwarz SKW, Puil E, MacLeod BA.Fung T, et al.Eur J Pharmacol. 2016 Nov 15;791:85-90. doi: 10.1016/j.ejphar.2016.08.005. Epub 2016 Aug 10.Eur J Pharmacol. 2016.PMID:27521870
- Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation.Montana MC, Gereau RW.Montana MC, et al.Curr Pharm Biotechnol. 2011 Oct;12(10):1681-8. doi: 10.2174/138920111798357438.Curr Pharm Biotechnol. 2011.PMID:21466446Free PMC article.Review.
- Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics.Varney MA, Gereau RW 4th.Varney MA, et al.Curr Drug Targets CNS Neurol Disord. 2002 Jun;1(3):283-96. doi: 10.2174/1568007023339300.Curr Drug Targets CNS Neurol Disord. 2002.PMID:12769620Review.
Cited by
- Metabotropic Glutamate Receptor 2/3 (mGluR2/3) Activation Suppresses TRPV1 Sensitization in Mouse, But Not Human, Sensory Neurons.Sheahan TD, Valtcheva MV, McIlvried LA, Pullen MY, Baranger DAA, Gereau RW 4th.Sheahan TD, et al.eNeuro. 2018 Apr 13;5(2):ENEURO.0412-17.2018. doi: 10.1523/ENEURO.0412-17.2018. eCollection 2018 Mar-Apr.eNeuro. 2018.PMID:29662945Free PMC article.
- Transmission pathways and mediators as the basis for clinical pharmacology of pain.Kirkpatrick DR, McEntire DM, Smith TA, Dueck NP, Kerfeld MJ, Hambsch ZJ, Nelson TJ, Reisbig MD, Agrawal DK.Kirkpatrick DR, et al.Expert Rev Clin Pharmacol. 2016 Oct;9(10):1363-1387. doi: 10.1080/17512433.2016.1204231. Epub 2016 Jul 4.Expert Rev Clin Pharmacol. 2016.PMID:27322358Free PMC article.
- Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain.Notartomaso S, Mascio G, Bernabucci M, Zappulla C, Scarselli P, Cannella M, Imbriglio T, Gradini R, Battaglia G, Bruno V, Nicoletti F.Notartomaso S, et al.Mol Pain. 2017 Jan;13:1744806917697009. doi: 10.1177/1744806917697009.Mol Pain. 2017.PMID:28326943Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources